Nov 17, 2026 9:31 am EST VolitionRx Highlights a Transformational Year: Clinical Validation, Commercial Partnerships, and Potential Upcoming Milestones
Nov 16, 2026 4:22 pm EST Volition Expands Contract with Fujifilm to Include the Nu.Q® Vet Test for Cats
Nov 12, 2026 4:10 pm EST VolitionRx Limited Announces Third Quarter 2026 Financial Results and Business Update
Nov 9, 2026 4:10 pm EST VolitionRx Limited Schedules Third Quarter 2026 Earnings Conference Call and Business Update
Oct 27, 2026 8:47 am EDT VolitionRx Signs LOI with Missionpharma to explore the Development and Launch of Volition's Lateral Flow Technology for NETosis Worldwide
Oct 27, 2026 8:17 am EDT VolitionRx Limited Announces $500,000 Partial Pre-Payment of Convertible Note in Cash
Sep 17, 2026 9:17 am EDT VolitionRx Shares Further Details and Video of the DETECSEPS Program Launch in France
Sep 14, 2026 8:17 am EDT VolitionRx Limited Announces Pre-Payment in Full of $7.5 million Senior Secured Convertible Promissory Note Due May 20, 2027
Sep 10, 2026 8:17 am EDT Volition Presents Early Stage I Solid Cancer Detection at the ESMO MAP Conference